Carcinoma of Unknown Primary — Trials

Carcinoma of Unknown Primary — Trials · CancerIndex

Clinical trials

Registered studies

14,232 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4,156
Recruiting: 2,259
Ph III recruiting: 269
Growth YoY: +12.3%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,893)

clinicaltrialsPublishedShowing 601–650 of 2,783 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06358469	STRatIfication of Vulvar SCC by HPV and p53 Status to Guide Excision(STRIVE)	recruiting	N/A	249	Canadian Cancer Trials GroupNETWORK	2	Aug 11, 2026	clinicaltrials
NCT06596954	Lymphocyte-sparing Thoracic Radiotherapy for Esophageal Squamous Cell Carcinoma	recruiting	N/A	212	Ruijin HospitalOTHER	1	Aug 11, 2026	clinicaltrials